Zhejiang Haisen Pharmaceutical Co Ltd
SZSE:001367
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Z
|
Zhejiang Haisen Pharmaceutical Co Ltd
SZSE:001367
|
CN |
|
CM Hospitalar SA
BOVESPA:VVEO3
|
BR |
|
Porto Seguro SA
BOVESPA:PSSA3
|
BR |
|
L
|
Live Nation Entertainment Inc
XETRA:3LN
|
US |
|
S
|
Sleeping Giant Capital Corp
XTSX:SSX.P
|
CA |
|
Patel Engineering Ltd
NSE:PATELENG
|
IN |
|
Mangalam Organics Ltd
NSE:MANORG
|
IN |
|
Victoria Gold Corp
TSX:VGCX
|
CA |
|
Cardiff Property PLC
LSE:CDFF
|
UK |
|
R
|
Recreate ASA
OSE:RCR
|
NO |
|
Enerside Energy SA
MAD:ENRS
|
ES |
|
Al Rajhi Banking & Investment Corporation SJSC
SAU:1120
|
SA |
|
C
|
China Vered Financial Holding Corporation Ltd
HKEX:245
|
HK |
|
M
|
MIX Telematics Ltd
JSE:MIX
|
ZA |
|
S
|
Speciality Restaurants Ltd
NSE:SPECIALITY
|
IN |
|
K
|
Know Labs Inc
AMEX:KNW
|
US |
Dividends
Dividend Yield
Zhejiang Haisen Pharmaceutical Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Zhejiang Haisen Pharmaceutical Co Ltd
Payout Ratio
Zhejiang Haisen Pharmaceutical Co Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Zhejiang Haisen Pharmaceutical Co Ltd is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Zhejiang Haisen Pharmaceutical Co Ltd
| Average Annual Return | -24.16% |
| Standard Deviation of Annual Returns | 23.55% |
| Max Drawdown | -64% |
| Market Capitalization | 3.9B CNY |
| Shares Outstanding | 152 350 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Zhejiang Haisen Pharmaceutical Co Ltd's latest stock split occurred on May 20, 2025
The company executed a 1-for-1 stock split, meaning that for every share held, investors received 1 new share.
Before the split, Zhejiang Haisen Pharmaceutical Co Ltd traded at 20.277 per share. Afterward, the share price was about 20.08.
The adjusted shares began trading on May 20, 2025. This was Zhejiang Haisen Pharmaceutical Co Ltd's 2nd stock split, following the previous one in Jun 18, 2024.
